Novo Holdings A/S’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Novo Holdings A/S’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-333,884	Closed	-$5M	–	40
2023 Q3	$5M	Hold	333,884	–	–	0.37%	33
2023 Q2	$10.8M	Buy	333,884 +58,373	+21%	+$2.13M	0.84%	29
2023 Q1	$10.8M	Hold	275,511	–	–	0.71%	36
2022 Q4	$14.6M	Hold	275,511	–	–	0.91%	31
2022 Q3	$12.4M	Hold	275,511	–	–	0.59%	31
2022 Q2	$10M	Sell	275,511 -557	-0.2%	-$20.2K	0.49%	37
2022 Q1	$11.4M	Buy	276,068 +128,511	+87%	+$4.52M	0.6%	28
2021 Q4	$6.29M	Hold	147,557	–	–	0.3%	42
2021 Q3	$8.12M	Hold	147,557	–	–	0.42%	35
2021 Q2	$7.06M	Hold	147,557	–	–	0.31%	43
2021 Q1	$7.47M	Buy	147,557 +67,455	+84%	+$3.75M	0.31%	41
2020 Q4	$5.04M	Sell	80,102 -45,326	-36%	-$2.81M	0.22%	42
2020 Q3	$8.43M	Sell	125,428 -20,000	-14%	-$1.09M	0.42%	32
2020 Q2	$6.09M	Sell	145,428 -40,614	-22%	-$1.56M	0.39%	31
2020 Q1	$5.86M	Sell	186,042 -58,958	-24%	-$2.36M	0.39%	19
2019 Q4	$9.89M	Hold	245,000	–	–	0.64%	19
2019 Q3	$7.97M	Buy	245,000 +100,000	+69%	+$3.98M	1.37%	16
2019 Q2	$7.03M	Buy	+145,000	New	+$6.17M	0.98%	20

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Novo Holdings A/S's SILK Position: Q4 2023 in Review

Novo Holdings A/S sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 333,884 shares — an estimated $5M sold.

Novo Holdings A/S first reported a position in SILK in Q2 2019 and held it in 18 quarters. The position peaked at $14.6M in Q4 2022. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

Novo Holdings A/S reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Novo Holdings A/S sold 333,884 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $5M.
Novo Holdings A/S first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
Novo Holdings A/S's Silk Road Medical, Inc. Common Stock position peaked at $14.6M in Q4 2022.
133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Novo Holdings A/S's 13F filing for Q4 2023, filed 14 Feb 2024.